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Background: We have shown in a randomized controlled trial that a computerized patient decision aid (P-DA)
improves medical knowledge and reduces decisional conflict, in early stage papillary thyroid cancer patients
considering adjuvant radioactive iodine treatment. Our objectives were to examine the relationship between
participants’ baseline information preference style and the following: 1) quantity of detailed information obtained
within the P-DA, and 2) medical knowledge.
Methods: We randomized participants to exposure to a one-time viewing of a computerized P-DA (with usual care)
or usual care alone. In pre-planned secondary analyses, we examined the relationship between information preference
style (Miller Behavioural Style Scale, including respective monitoring [information seeking preference] and
blunting [information avoidance preference] subscale scores) and the following: 1) the quantity of detailed information
obtained from the P-DA (number of supplemental information clicks), and 2) medical knowledge. Spearman correlation
values were calculated to quantify relationships, in the entire study population and respective study arms.
Results: In the 37 P-DA users, high monitoring information preference was moderately positively correlated with higher
frequency of detailed information acquisition in the P-DA (r = 0.414, p = 0.011). The monitoring subscale score
weakly correlated with increased medical knowledge in the entire study population (r = 0.268, p = 0.021, N = 74), but not
in the respective study arms. There were no significant associations with the blunting subscale score.
Conclusions: Individual variability in information preferences may affect the process of information acquisition from
computerized P-DA’s. More research is needed to understand how individual information preferences may impact
medical knowledge acquisition and decision-making.
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Patient decision aids (P-DAs) inform patients about
healthcare choices and they have been shown to improve
patients’ knowledge of medical choices, accuracy of ex-
pectations of risks and benefits of choices, and participa-
tion in decision-making [1]. A large number of P-DAs,
in such forms as computerized programs, brochures, de-
cision boards, videotapes, and others, are available for
use in cancer care. [2]. Furthermore, the use of cancer
care P-DAs is associated with improved medical know-
ledge and reduced decisional conflict [2].
The International Patient Decision Aid Standards Col-
laboration has developed quality evaluation criteria for
P-DAs, and such criteria encompass informational con-
tent, development process, and effectiveness in ensuring
that decision-making is informed and values-based [3].
Such quality criteria include standardization of informa-
tional content, including presentation of numerical de-
scriptions of event rates and probabilities of outcomes [3].
Internet-based P-DAs are a contemporary development in
the field [4], and of particular interest to this study. An
international, multidisciplinary panel of scientists recently
reported on theoretical literature and empirical evidence
the from a variety of disciplines supporting internet-based
P-DAs, including the Health Belief Model, Social Cog-
nitive Theory, Elaboration Likelihood Model, Theory of
Goal Setting and Performance, and Stages of Change
Theory [4]. This group of experts recommended more
research be performed using internet-based P-DAs,
examining issues such as interactivity of users [4].
In searching for health information on the internet, it
is known that individuals’ personal information prefer-
ences impact searching behavior [5]. Furthermore, there
is some research suggesting that matching information
messages to patients’ information preference increases
positive health behaviour, such as screening mammog-
raphy [6, 7]. A need for more research in matching the
way information is presented to individual patient pref-
erences (‘patient-match’) has been called for [8]. In the
area of internet-based P-DAs, the relationship between
users’ information-seeking style and quantity of informa-
tion obtained from P-DAs (i.e. interactivity of user traits
with such programs) and resultant knowledge acquisi-
tion, is not known. Such research is critical in develop-
ing an understanding of whether personalization of
internet-based P-DAs to the information preferences of
the user, may be potentially beneficial.
We recently developed and tested a patient-directed
computerized (internet-based) P-DA, explaining the
choice of adjuvant radioactive iodine (RAI) or no RAI,
for early stage papillary thyroid cancer [9–13]. In a ran-
domized controlled trial comparing the use of this P-DA
(with usual care) to usual care alone, we found that one
time P-DA exposure was associated with a significantimprovement of medical knowledge and reduction in de-
cisional conflict, compared to no P-DA exposure [13].
The level of informational detail desired by thyroid
cancer patients in medical decision-making is highly
variable, with some individuals preferring detailed (in-
cluding numerical probability) information, and others
strongly preferring to avoid such details (particularly
“the numbers”) [14]. Such variability may be due to dif-
ferences in general information preference style in re-
sponse to health threats. Miller [15–17] has designated
two main information preference styles in potentially
threatening circumstances: monitoring (seeking out and
attending to threatening information), and blunting
(avoiding threatening information and cognitively dis-
tracting from it).
We have previously reported, in a qualitative study, that
thyroid cancer survivors indicated a need for a P-DA,
explaining the choice of accepting or rejecting adjuvant
radioactive iodine treatment, and the medium of choice
for such was a computerized (internet-based) P-DA, with
the ability to print the informational content [14]. As we
understood from our prior research [14], that the potential
users of a thyroid cancer adjuvant radioactive iodine treat-
ment P-DA, expressed strong, variable, individual prefer-
ences for level of detail of relevant information, we
developed a computerized P-DA that provides patients
with the option of accessing textboxes containing supple-
mental detailed (largely numerical) information, or, alter-
natively, avoiding such details (by not clicking on the
relevant textboxes). The rationale for this approach was to
allow users’ who preferred to view detailed, largely numer-
ical, information to easily access it by clicking on a link;
furthermore, we enabled users who preferred to avoid
such information, the option of simply not clicking on the
related detailed information links. In this way, we planned
for our P-DA to respect users’ autonomy, in deciding what
level of detail each individual wanted to access, in the
decision-making process.
In this pre-planned secondary analysis, we examined the
relationship between patients’ information preference style
and the following: 1) the number of times supplemental
detailed information was obtained by P-DA users (i.e. the
number of clicks on supplemental information within text
boxes), and 2) medical knowledge. In a post-hoc second-
ary analysis that was suggested by a reviewer, we also ex-
amined the relationship between patients’ information
preference style and decisional conflict. Our primary hy-
pothesis was that DA users with higher monitoring infor-
mation preference style would more frequently access the
links to additional detailed information. It is important to
note that randomization in this trial was not stratified by
patients’ post-randomization information preferences, and
so all secondary analyses presented herein should be con-
sidered hypothesis-generating.
Sawka et al. BMC Medical Informatics and Decision Making  (2015) 15:48 Page 3 of 8Methods
Trial design
We conducted a single-center parallel design randomized
controlled trial, and allocated 74 consenting adults with
early stage PTC in 1:1 fashion, using central computerized
randomization, to either a one-time exposure to a patient-
directed computerized P-DA, or no P-DA [Clinical
Trials.gov identifier NCT01083550 and (12;13)] (Fig. 1).
CONSORT guidelines for trial reporting were followed
[18] (see Additional file 1). Blinding of patients, their
physicians, and study and study personnel after allocation
was not possible. The statistical analyses were un-blinded
for secondary outcomes reported in this manuscript. The
computerized randomization sequence incorporated ran-
dom block sizes of 2 and 4 and was developed by an off-
site study statistician [13]. The randomization allocation
was revealed to each participant using the DA program, by
a research staff member, immediately prior to the interven-
tion allocation. The development of the P-DA included,Fig. 1 CONSORT flow diagramqualitative input from patient participants on relevant infor-
mation needs [14], execution of multiple relevant system-
atic reviews [19–23], and two phases of usability testing of
respective prototypes of the P-DA (including feedback from
patients, and physicians) [9–11]. This trial was approved by
the University Health Network Research Ethics Board and
all participants provided written, informed consent. As pre-
viously reported [13], the inclusion criteria were: individuals
aged ≥18 years, who had a total thyroidectomy (completed
in one or two stages) on or after September 1, 2009, and
whose clinic-pathologic diagnosis was low risk papillary
thyroid cancer (PTC) (i.e. primary tumor 1 to 4 cm in
diameter, with no distant nor nodal metastases, no extra-
thyroidal extension of the PTC, no vascular nor lymphatic
invasion, and with no tall cell histologic features). Par-
ticipants were required to be fluent in English (written
and verbal, ascertained by self report), physically able
to use a computer (by self-report), and provide in-
formed consent [13]. We did not pre-test potential
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level of computer proficiency, prior to enrollment in
the trial. Participants in the P-DA group self-navigated
the P-DA website for up to 60 min at one sitting, on a
PC desktop computer, located in a research office at
University Health Network. A research assistant who
was present in the room, directed each individual to re-
view a set of general instructions at the beginning of
the P-DA program (on the first webpage), explaining
how to navigate the program, access supplemental in-
formation, adjust font size, and print content. However,
the research staff member did not assist the partici-
pants with navigation of the P-DA, nor any other pro-
cedures. P-DA users were required to visit the 16 web
pages within the P-DA, but provided the option to ac-
cess supplemental detailed information, presented
within text boxes, labelled with an “i” and the title
“More Information.” There was no limit on the number
of times that P-DA group participants could access
supplemental detailed information during the study
visit, but self-navigation time was limited to a max-
imum of 60 min. No P-DA access was available outside
the study. All participants received usual counselling
and care from their treating physicians, but there was
no standardization of the verbal consultations nor sup-
plemental materials (eg. brochures) associated with
usual care visits. All participants had been seen by at
least one thyroid cancer specialist on at least one occa-
sion, prior to viewing the P-DA. All participants were
subsequently clinically followed by thyroid cancer
specialists.
Outcomes
The results of the trial primary outcome analysis, com-
paring medical knowledge between P-DA and no P-DA
groups, has been previously reported [13]. The sample
size justification of 74 participants has been previously
described, for the primary outcome analysis [13], and
was used as a convenience sample for all secondary ana-
lyses. The post-randomization (study baseline) informa-
tion preference style was measured by respective
monitoring and blunting subscale scores of the Miller
Behavioural Style Scale (MBSS) [15, 16], prior to any ex-
posure to the P-DA (or no P-DA in the case of the con-
trol group, i.e. at a concurrent time point in the study,
relative to recruitment). The MBSS is a 32-item tool in
which 4 hypothetical non-medical scenarios are pre-
sented (including dental work, a terrorist hostage-taking,
a potential imminent employment termination, and in-
flight airplane problem), followed by choices that may be
categorized as either monitoring (16 choices) or blunting
(16 choices) style responses; the subscale scores for
monitoring and blunting are respectively calculated by
summing the number of positive responses in eachcategory (maximum score of 16 for each category)
[15, 16]. The quantity of supplemental detailed medical
information actively sought by P-DA users was mea-
sured by the number of clicks on text boxes titled “More
Information.” There were a total of 21 such text boxes
located throughout the P-DA, and when a participant
clicked on one of these text boxes or icons, an event was
identified. Multiple clicks on the same text box at separ-
ate discrete time points were individually counted to-
ward the total number of clicks (for participants who
returned to a textbox after closing it). The data on num-
ber of clicks for more information was collected within
the P-DA. Detailed numerical information was included
in such text boxes, but not all of the detailed informa-
tion was necessarily numerical. Medical knowledge was
assessed using a previously validated 10-item true/false
questionnaire, focused on early stage PTC and informa-
tion relevant to the choice to accept or reject adjuvant
radioactive iodine treatment (score represented by the
total number of correct responses) [9, 10]. The medical
knowledge questionnaire includes 10 questions (true or
false) on the following topics: low PTC prognosis, radio-
active iodine treatment procedure (including prepar-
ation), potential radioactive treatment side effects,
medical follow-up implications of radioactive iodine
treatment, and the best available medical evidence on
the impact of radioactive iodine treatment on long-term
thyroid cancer outcomes [9, 10]. The knowledge ques-
tionnaire was scored by the number of correct responses
(maximum possible score of 10 out of 10) [9, 10]. Deci-
sional conflict on the decision to accept or reject radio-
active iodine treatment was measured using a previously
validated questionnaire [24, 25]. All questionnaires were
self-administered by the participants, using pen and
paper, under the supervision of a research assistant.
Statistical methods
Data were analyzed in an intention-to-treat fashion.
Descriptive data were summarized using numbers and
percentages; continuous data were summarized using
means and standard deviations (SD, or ranges). An
alpha level of 0.05 was the cut-off for statistical signifi-
cance for all analyses. In these pre-planned secondary
analyses, we examined Spearman’s correlations (r) between
respective baseline monitoring and blunting information
preference style subscale measurements (using the Miller
Monitor-Blunter Style Scale) and a) the amount of supple-
mental detailed information obtained in the P-DA program
(measured by the number of clicks for more information),
as well as b) score on a medical knowledge questionnaire in
the entire study population, as well as in the respective
P-DA and control groups. A post-hoc correlation ana-
lysis was performed, examining the relationship be-
tween respective baseline monitoring and blunting
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(using the Miller Monitor-Blunter Style Scale) and de-
cisional conflict, as per recommendation of a reviewer.
We also performed a post-hoc exploratory Spearman’s
correlation analysis examining the relationship between
the amount of supplemental detailed information ob-
tained and medical knowledge. The rationale for this
post-hoc analysis was to explore whether there was a
relationship between the amount of informational con-
tent obtained by participants and ultimate success in
knowledge acquisition (i.e. to understand if obtaining
more detailed information related to more knowledge).
Quantitative statistical analyses were performed using
PASW Statistics 18.0 (IBM, Chicago, IL).
Results
Participant characteristics
There were 74 study participants recruited, including 37
who were exposed to the P-DA, and 37 controls, who were
not exposed to the P-DA. The details of the demographic
and disease characteristics of the study population have
been previously reported [13]. As reflected in Table 1, the
respective P-DA and control groups were similar in terms
of gender, age, level of education, and frequency of com-
puter use. All 37 participants in the P-DA group were able
to complete the viewing of the 16 web pages within the al-
lotted time (maximum 60 min). As previously reported
[13], the mean time spent viewing the P-DA was about
30 min, and ranged from 11 to 60 min, and none of the
participants reported any major difficulties navigating the
site. None of the participants in the control group viewed
the DA at any time point before, during, or after the study.
There was no harm reported to participants in this study.
The Miller Monitoring subscale result for the entire study
population was a mean of 10.6 (out of a maximum of 16),
standard deviation 2.7, minimum 3, maximum 16 (data
from 74 individuals). The Miller Blunting subcale result for
the entire study population was a mean score of 4.0 (out of
a maximum of 16), standard deviation 2.3, minimum 0,
maximum 10 (data from 74 individuals). For the entire
study population of 74 individuals, the mean medicalTable 1 Participant characteristics
Characteristic
Females
Mean Age in Years (Standard Deviation)
Highest Education Attained High School or Lower
College or University
Self-report Frequency of Computer Use Utilize computer most days
Miller Behavioural Style Scale Scores Mean Monitoring Subscale Scor
Mean Blunting Subscale Score (S
Measured using the Miller Behavioural Style Scale (maximum value for each measuknowledge score was 8.8 (out of a maximum of 10), stand-
ard deviation 1.4, minimum of 4, and maximum of 10. For
the entire study population (n = 74), the mean decisional
conflict score (out of a maximum of 100) was 38.6, stand-
ard deviation 22.5, minimum 2, maximum 98. As previ-
ously reported [13], the mean medical knowledge score in
the P-DA group was 9.7 out of 10 (standard deviation 0.6,
from n = 37 participants), which was significantly higher
than the mean score of 7.8 (standard deviation 1.3 from
n = 37 participants) in the control group (p < 0.001 for
the comparison). Furthermore, as previously reported
[13], decisional conflict score was significantly lower in
the P-DA group (mean score of 25.2, standard devi-
ation 13.4 from n = 37 participants) compared to the
control group (mean score of 52.1, standard deviation
21.9 from n = 37 participants) (p < 0.001 for the differ-
ence). The Miller Monitor subscale results according to
randomization status were as follows: P-DA group,
mean score (out of a maximum of 16) was 10.9, stand-
ard deviation 2.8, minimum 3, maximum 16, from 37
individuals, control group mean score 10.2, standard
deviation 2.3, minimum 5, maximum 15, from 37 indi-
viduals. The Miller Blunting subscale results according
to randomization status were as follows: P-DA group,
mean score (out of a maximum of 16) was 4.0, standard
deviation 2.4, minimum 1, maximum 10, from 37 individ-
uals, control group mean score 4.1, standard deviation 2.3,
minimum 0, maximum 9, from 37 individuals. For the 37
individuals in the P-DA group, the mean number of clicks
to obtain “More Information” was 11.1 (standard deviation
10.9, range from 0 to 41).
Information preference style and supplemental P-DA data
obtained
Our first objective was to determine whether there was a
relationship between participants’ information preference
style and the quantity of supplemental information ob-
tained in the P-DA program by clicking for “More Infor-
mation”. We found a significant moderate positive
correlation between the monitoring (higher information




31 (84 %) 31 (84 %)
48 (12) 44 (12)
4 (11 %) 5 (14 %)
33 (89 %) 32 (86 %)
34 (92 %) 36 (98 %)
e (Standard Deviation) 10.9 (2.8) 10.2 (2.6)
tandard Deviation) 4.0 (2.4) 4.1 (2.3)
re = 16)
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tion” clicks (r = 0.414, p = 0.011). However, there was no
significant relationship between the blunting (information
avoidance preference) subscale score and the number of
clicks for supplemental information (r = 0.117, p = 0.489)
in the P-DA group (n = 37).Information preference style and medical knowledge
acquired
A second objective was to determine whether there was a
relationship between the individual information preference
style and medical knowledge, for the entire study popula-
tion, as well as the intervention and control subgroups,
respectively. For the entire study population of 74 indi-
viduals, the monitoring subscale score was significantly,
weakly positively correlated with the number of correct
responses on a thyroid cancer medical knowledge ques-
tionnaire (r = 0.268, p = 0.021); however, the blunting
subscale score was not associated with the medical
knowledge score (r = −0.124, p = 0.292). For the 37 indi-
viduals in the P-DA group, there was no statistically
significant association between monitoring subscale
score and number of correct responses on the medical
knowledge questionnaire (r = 0.277, p = 0.097), but the
relatively small size of this subgroup likely limited statistical
power of this analysis, given the observed trend. Further-
more, the blunting subscale score was not associated
with medical knowledge questionnaire score (r = 0.031,
p = 0.855) in P-DA users. For the 37 individuals in the
control group, medical knowledge was also not signifi-
cantly associated with either the monitoring subscale
score (r = 0.221, p = 0.189), nor the blunting subscale
score (r = −0.246, p = 0.143).Post-hoc exploratory analysis examining information
preference style and decisional conflict
In a post-hoc exploratory statistical analysis suggested by a
reviewer, we examined whether information preference
style was associated with decisional conflict in the entire
study population as well as in the respective subgroups
(P-DA and control). Decisional conflict was measured
post-P-DA intervention in the P-DA group. We found
no statistically significant relationships between decisional
conflict and the Miller Monitoring subscale score in the en-
tire study population (r = −0.020, p = 0.866, n = 74), P-DA
group (r = −0.029, p = 0.867, n = 37), nor in the control
group (r = 0.127,p = 0.454, n = 37). Furthermore, we found
no statistically significant relationships between decisional
conflict and the Miller Blunting subscale score in the entire
study population (r = 0.002, p = 0.987, n = 74), P-DA group
(r= 0.278, p = 0.096, n = 37), nor control group (r = −0.227,
p = 0.176, n = 37).Post-hoc exploratory analysis examining quantity of
supplemental information obtained and medical
knowledge
In a post-hoc exploratory statistical analysis in the P-DA
group, there was no relationship between the number of
clicks for supplemental detailed information and the
medical knowledge score (r = −0.154, p = 0.361) (n = 37).
Although statistical power of this analysis was limited,
the inverse relationship suggested that accessing supple-
mental detailed information was unlikely to be a major
contributor to medical knowledge.
Discussion and conclusions
We observed a high degree of variability among thyroid
cancer patients, in the quantity of additional detailed in-
formation sought within a computerized P-DA on RAI
decision-making. We also observed that that high moni-
toring information preference style was associated with
increased frequency of obtaining such supplemental
from the P-DA. These findings are consistent with re-
sults of prior studies of oncology patients, indicating that
high monitoring style is associated with general prefer-
ence for more detailed medical information [26] and, in
the case of oncologic healthcare consultations, increased
number of questions posed by the patient [26, 27]. High
monitoring subscale score on the Miller Behavioural
Style questionnaire has also been associated with in-
creased utilization of specialized sources of information
by breast cancer patients, particularly relating to medical
books or journals [28]. We did not observe a significant
relationship between blunting style and information ob-
tained from the P-DA. In previous studies, Ong et al. re-
ported that a blunting style was not correlated with
desired level of detail of cancer-related information [26],
whereas Timmermans et al. reported that higher blunt-
ing subscale scores were significantly associated with
fewer questions posed by patients during palliative
radiotherapy consultations, but not curative radiotherapy
consultations [27]. Differences in the tools used to meas-
ure blunting or differences in study populations, could
potentially explain the variability in these findings. We
did not find convincing evidence to suggest that in-
creased rate of obtaining of detailed information im-
proved medical knowledge scores. Our results also fail
to support the assumed (or intuitive) model that a pref-
erence to seek more information (high monitoring style)
leads to significantly more medical knowledge in com-
puterized P-DA users. More future research is needed,
ideally in larger studies, to verify our findings and better
understand the potential clinical impact.
The strengths of this study include: its novelty as the
first study of computerized P-DAs exploring the quantity
of information sought by users as well as the relationship
between individual information preferences and the
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ledge, the standardization to the procedure in which the
P-DA was presented (i.e. in a research office, timed use,
no exposure to the P-DA intervention before or after the
session), complete data collection (i.e. no missing data),
the automated recording of the number of clicks for
supplemental information obtained within the P-DA by
participants, and the utilization of a well-established, val-
idated tool for measurement of information preference
style. Some of the limitations include the following: this
is a secondary analysis and the randomization was not
stratified according to information preference (so the
trial was not specifically designed to primarily address
whether information preference impacts other outcomes
and as such, results are hypothesis-generating), the sam-
ple size was relatively small so the secondary analyses
(including subgroup analyses) may have been statistically
underpowered, potential selection bias (most partici-
pants reported using computers on most days and most
were well-educated, further all were fluent in written
and spoken English), lack of standardization of the coun-
seling (or any related materials) received by treating phy-
sicians as part of usual care, and limited external
generalizability to healthcare decisions or other comput-
erized P-DAs where users do not have the option to
choose to view additional information or not.
In conclusion, our study demonstrates the variability
that exists among thyroid cancer patients, in terms of in-
dividual information seeking preferences, and resultant
quantity of detailed information retrieved from a com-
puterized P-DA. Although hypothesis-generating, our re-
sults also raise some questions about the incremental
value of mandating presentation of detailed numerical
data within P-DA’s, as some patients may prefer not to
view such data, and it is not clear that those who view it,
acquire more fundamental medical knowledge (as com-
pared to a simpler explanation). An important implica-
tion of our findings for developers of P-DAs and
researchers, is the introduction of the concept of person-
alizing knowledge translation to the information prefer-
ences of users. Internet-based P-DAs may be particularly
amenable to personalized modifications, allowing users
to navigate links, based on information preferences. Yet,
to some extent, tailoring informational detail in decision
support tools by allowing some users to avoid detailed
numerical probability information according to their
preferences could be at odds with current P-DA quality
standardization initiatives [3]. Future studies are needed,
to explore whether personalization of format and the
level of detail of content (particularly relating to numer-
ical data) of P-DAs to users’ preferences may enable
optimization of knowledge translation outcomes, or at
least be non-inferior to current methods, but potentially
preferred by some users. Such research is critical inadvancing our understanding of the evolving role of
personalization of decision support tools in advancing
patient autonomy regarding provision of information in
medical decision-making.
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